| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5712b4838bdb16ebbc41121239e165b9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-45 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 |
| filingDate |
1974-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1975-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_501bb49dbf674389a352a465c8ff3396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_949756599c42842ffc58ee9495f0d9d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a153bcdca977b36620a30a3da50726b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b5f00d14af93b367c3ae6d95c9f8c8d |
| publicationDate |
1975-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3920845-A |
| titleOfInvention |
2-nitroindan-1,3-dione |
| abstract |
Allergic conditions such as asthma, hay fever and rhinitis are treated with daily doses of 2-nitroindan-1,3-dione or the equivalent amount of a pharmaceutically acceptable salt orally, parenterally or by insufflation. The salt is an alkali metal salt or a salt with an organic base such as an amine or amino compound. The average daily dose is 400-700 mg. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007258971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007060517-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8431535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4014907-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7807639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4017639-A |
| priorityDate |
1971-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |